A 62-year-old woman with a history of curatively treated mucinous ovarian cancer, presented with dyspnea, anorexia and right-upper-quadrant pain at consultation with her general practitioner. A CT scan revealed several lymph node metastases in lungs and abdomen as well as a tumor in Morrison's pouch and biopsy revealed renal cell carcinoma. Therefore, she was referred to Department of Urology. The multidisciplinary team could not immediately reject that there could be an exophytic tumor in the right kidney but discrepancy between histology and imaging, led to several biopsies including laparoscopic procedure. Re-examination of the primary ovarian cancer showed that one percent was classified as clear cell carcinoma. The final diagnose was metastatic clear cell ovarian carcinoma. The patient was terminal and suffered of cachexia and pleural effusion. The patient deceased four months after first consultation.
Introduction
Incidence of new ovarian cancer in Europe in 2012 is estimated to 65,538 [1] and for kidney cancer 43,435 (women) [2] . There is variation in the incidence rate across the continent with a higher incidence of ovary cancer in northern European countries, with Denmark having the second highest in the world [3] .
Ovarian cancer often has no symptoms at the early stages, so the disease is generally advanced when it is diagnosed and therefore it has a poor prognosis [4] . Symptoms can be abdominal pain, urinary symptoms, constipation and abdominal swelling with weight loss. Furthermore, these patients have a lower rate of survival relative to many other cancer disease sites. An estimated 70% -75% of patients will experience a recurrence [5] with a median time to recurrence of 18 -24 months [6] .
The most common type of kidney cancer is clear cell renal carcinoma [7] which accounts for 75% -90% of all cases. Clear cell adenocarcinoma of the ovary is less common, about 3% -10% [8] . It classifies as a so-called Type 1, like mucinous carcinomas, which are slow growing tumors and often diagnosed in lowest stadium I, despite of the frequently large size. Clear cell carcinoma of the ovary is per definition highly malignant and has a worse prognosis compared to other cell types [9] .
Here we report on a patient with metastatic clear cell ovarian cancer years after intended curative treatment. 
Patient Presentation

Discussion
This patient had difficult diagnostic challenges for several reasons. First, the tumor had close relation to the right kidney. From the CT scan the kidney appeared to be well defined and without irregularities but as mentioned it is difficult to contradict histological analysis. Second, the morphology for clear cell renal cell carcinoma is not unique and makes it challenging to distinguish between other clear cell variants.
By immunohistochemically staining, renal cell carcinoma is positive for CD10 and renal cell carcinoma monoclonal antibody (RCCma), while being negative for Ca-125.
Nevertheless it has been suggested, that PAX2 and PAX8 are more stable markers. Unfortunately, they are both also positive regarding clear cell from the ovary [10] . This patient was amongst others negative for estrogen, Ca-125, CD10 and PAX8.
Renal cell carcinoma metastasize locally to vena renalis et cava and perirenal as well as hematogenous dissemination to liver, lungs and bone [7] . By hematogenous dissemination, the cells go through several steps of both intra-and extravasation before it can metastasize to other organs. The biology of ovarian carcinoma differs from that of hematogenously metastasizing tumors because ovarian cancer cells primarily disseminate within the peritoneal cavity-the peritoneum and omentum, but occasionally there can be lymphogenous involvement-primarily paraaortic [11] .
Regarding survival of type 1 ovarian cancer, mucinous cancers have a better prognosis compared to clear cell [3] . Never the less it has not been possible to reduce mortality in clear cell stadium IA-IB by giving adjuvant chemotherapy and it is therefore not recommended in Denmark [3] . Overall, diagnosed ovarian cancer often reveals an advanced stage with metastasis and is therefore associated with high mortality. Dissemination is believed to involve less steps, because only a single cell or a group of cancer cells will have to release from the primary tumor. The transportation of cells is passive mechanism by movement of the peritoneal fluid, which gives multiple possibilities of sites for metastasis [11] .
Immunohistochemical staining are our reliable way to make histological diagnoses, but in this case, the patient's primary histology was reassessed for clarification.
Conclusion
In conclusion, metastasis of previous cancer is of great importance in differential diagnosis. One should consider it a likely diagnosis even though primary cancer was of lower TNM and completed curative treatment.
